Journals / Nöropsikiyatri Arşivi / 2013 / Cilt: 50 - Sayı: 2

Antiphospholipid-Antibody-Negative Sneddon's Syndrome: A Case Report and Review of the Literature

Otoantikorları Negatif Sneddon Sendromu: Olgu Sunumu ve Literatürün Gözden Geçirilmesi

Pages
180–182
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In this case report, we aimed to discuss clinical manifestations, pathological findings in the skin lesions and neuroradiological findings in a patient with antiphospholipid-antibody-negative Sneddon's syndrome and wanted to share our treatment approach. ( Archives of Neuropsy chiatry 2013; 50: 180-182 )

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Sneddon's Syndrome is a systemic disease characterized by livedo reticularis and cerebrovascular lesions.
📊
Key Findings & Data:A 48-year-old female with a history of hypertension, 6 miscarriages and one stillbirth presented to our clinic with acute left-sided weakness and vision loss.
💡
Conclusion & Impact:In this case report, we aimed to discuss clinical manifestations, pathological findings in the skin lesions and neuroradiological findings in a patient with antiphospholipid-antibody-negative Sneddon's syndrome and wanted to share our treatment approach. ( Archives of Neuropsy chiatry 2013; 50: 180-182 )
🔬Design:Research Article
📍Scope:2013 Verileri
⚙️Variables:Domain Parameters

Abstract

Sneddon's Syndrome is a systemic disease characterized by livedo reticularis and cerebrovascular lesions. Its clinical presentation varies widely and its etiology is still unknown. Other symptoms that can accompany are cognitive decline, epilepsy, headache, miscarriages and hypertension. A 48-year-old female with a history of hypertension, 6 miscarriages and one stillbirth presented to our clinic with acute left-sided weakness and vision loss. Physical examination showed blue-purple skin marks with irregular borders on her upper and lower extremities. The patient’s neurological examination revealed eft homonymous hemianopia, mild hemiparesis of distal upper extremities and globally hyperactive deep tendon reflexes. Brain imaging confirmed a subacute right occipital infarct and showed chronic infarcts in the left frontal and temporal obes, bilateral cerebellar infarctions and ischemic changes in the periventricular regions. Anticardiolipin antibodies and lupus anticoagulant were negative. Factor V Leiden mutation was not found, homocysteine, Protein S and protein C activity and fibrinogen levels were within the normal ranges. Titre of antinuclear antibodies (ANA) was over 1/100. Neuropsychological testing revealed mild memory difficulties. The skin biopsy was compatible with Sneddon’s syndrome. The patient was diagnosed with Sneddon's syndrome based on historical, clinical and laboratory findings and antiaggregant therapy was initiated. In this case report, we aimed to discuss clinical manifestations, pathological findings in the skin lesions and neuroradiological findings in a patient with antiphospholipid-antibody-negative Sneddon's syndrome and wanted to share our treatment approach. ( Archives of Neuropsy chiatry 2013; 50: 180-182 )

Özet

Sneddon Sendromu ciltte livedo retikülaris ve tekrarlayan serebrovasküler ataklarla karakterize, otoimmün olduğu düşünülen ve nadir görülen bir hastalıktırTekrarlayan düşükler, nöbet, kognitif yetmezlik, hipertansiyon hastalıkta görülen diğer semptomlardır. 48 yaşında kadın hasta görme bozukluğu, sol taraf güçsüzlüğü şikayeti ile başvurduÖzgeçmişinde hipertansiyon ve altı düşük, bir ölü doğum öyküsü mevcuttu. Fizik muayenesinde her iki üst ve alt ekstremitede mavi-mor renkli düzensiz sınırlı cillezyonları mevcuttu. Nörolojik muayenesinde sol homonim hemianopsi, her iki üsekstremite distallerinde früst parezi ve derin tendon reflekslerinde canlılık saptandıBeyin görüntülemesinde sağ oksipital subakut enfarkt, sol temporal, her iki serebellave sol frontal kronik enfarkt alanları ve periventriküler iskemik değişiklikler mevcuttuAntikardiolipin antikorları ve lupus antikoagülanı negatif, fibrinojen, homosisteinprotein-C, protein aktivitesi normal sınırlardaydı, faktör 5 Leiden mutasyonu saptanmadı, ANA 1/100 titrede pozitif idi. Nöropsikometrik testte orta derecede bellek bozukluğu vardı. Lezyonlu bölgeden yapılan cilt biyopsisinde Sneddon Sendromuyla uyumlu biyopsi bulguları saptandı. Özgeçmiş, klinik ve laboratuvar sonuçları ile Sneddon Sendromu tanısı düşünülen hastaya antiagregan tedavisi başlandı. Bu olgu sunumunda Sneddon Sendromunun tipik bulgularını gösteren ve otoantikorları negatif saptanan bir hastanın klinik göstergeleri, cilt biyopsisi ve nöroradyolojik bulgularının tartışılması ve tedavi yaklaşımımızın paylaşılmasamaçlanmıştır. ( Nöropsikiyatri Arşivi 2013; 50: 180-182)

🔖

Cite This Article

ARSLAN, E., DİRİCAN, A. C., ERTEM, D. H., ALTUNKAYNAK, Y., BAYBAŞ, S., ÖZKAN, Y. (2013). Antiphospholipid-Antibody-Negative Sneddon's Syndrome: A Case Report and Review of the Literature. Nöropsikiyatri Arşivi, Cilt: 50 - Sayı: 2, 180–182. https://ajindex.com/articles/292526

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Sneddon IB. Cerebrovascular lesions and livedo reticularis. Br J Dermatol 1965; 77:180-185. Lockshm MD. Antiphospholipid antibody syndrome. In: Mc Cune WJ, ed. Rheumatic disease clinics of North America 1994; 20:45-59.
  2. Kalashnikova LA, Nasonov EL, Kushekbaeva AE, Gracheva LA. Anticardiolipin antibodies in Sneddon's syndrome. Neurology 1990; 40:464-467.
  3. Otoyama K, Katayama I, Suzuki Y ve ark. A case of Sneddon's syndrome with positive ANA and Anti-cardiolipin antibodies: Primary anti- phospholipid syndrome? J Dermatol 1990; 17:489-492.
  4. Levine SR, Langer SL, Albers JW, Welch KM. Sneddon's syndrome: An antiphospholipid antibody syndrome? Neurology 1988; 38:796-800.
  5. Bolayir E, Yilmaz A, Kugu N, Erdogan H, Akyol M, Akyuz A. Sneddon’s Syndrome: Clinical and Labrotary Analysis of 10 case. Acta Med. Okayama 2004; 58:59-65. Francès C, Piette JC. The mystery of Sneddon syndrome: relationship with antiphospholipid syndrome and systemic lupus erythematosus. J Autoimmun 2000; 15:139-143.
  6. Zelger B, Sepp N, Stockhammer G, Dosch E, Hilty E, Ofner D, Aichner F, Fritsch PO. Sneddon's syndrome. Arch Dermatol 1993; 129:437-447.
  7. Weissenborn K, Lubach D, Schwabe C, Becker H. Sneddon's syndrome: clinical course and outcome. J Neurol 1989; 236:34-37.
  8. Stockhammer G, Felber SR, Zelger B, Sepp N, Birbamer GG, Fritsch PO, Aichner FT. Sneddon's Syndrome: Diagnosis by Skin Biopsy and MRI in 17 Patients. Stroke 1993; 24:685-690.
  9. Rebollo M, Val JF, Garijo F, Quintana F, Berciano J. Livedo reticularis and cerebrovascular lesions (Sneddon's syndrome). Brain 1983; 106:265-268.
  10. Zelger B, Sepp N, Stockhammer G, Dosch E, Hilty E, Ofner D, Aichner F, Fritsch PO. Sneddon’s Syndome.A Long-term Fallow –up of 21 Patients.Arch Dermatol 1993; 129:437-447.
  11. Yiğit A, Erdem H, Aydın N, Mutluer N. Sneddon sendromu. Yeni Tıp Dergisi 1994; 11:61-64.
  12. Fransway AF, Muller SA. Neurocutaneous diseases. In: Moschella SL, Hurley HJ. Dermatology. 3rd ed. WB Saunders Company, 1992: s. 2074. Burton JL. Livedo reticularis, porcelain-white scars and cerebral thromboses. Lancet 1988; 2:1263-1264.
  13. Jura E, Palasik W, Meurer M, Palester-Chlebowczyk M, Czlonkowska A. Sneddon's syndrome (livedo reticularis and cerebrovascular lesions) with antiphospholipid antibodies and severe dementia in a young man: a case report 1994; 89:143-146.
  14. Wright RA, Kokmen E. Gradually progressive dementia without discrete cerebrovascular events in a patient with Sneddon’s syndrome. Mayo Clin Proc 1999; 74:57–61. Mutluer N, Yiğit A, Aydın N. Sned